InMed Pharmaceuticals Inc. said it received conditional approval to list its common shares on the Toronto Stock Exchange.
Final approval is subject to customary listing conditions which the company expects to meet before the May 29 deadline.
The Vancouver, British Columbia-based company's shares will continue to trade under the symbol IN.
Further, InMed plans to voluntarily delist its common shares from the Canadian Stock Exchange. The delisting will take effect on the date the company's shares begin trading on TSX.
InMed develops cannabinoid-based prescription drug therapies.
